Year: 2025

Philips builds strong order intake momentum and drives margin expansion in Q2

Written by Customer Service on July 29, 2025. Posted in Earnings Releases And Operating Results.

July 29, 2025 Q2 2025 Group HighlightsComparable order intake growth 6% Group sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow; reiterates comparable sales growth outlookRoy Jakobs, CEO of Royal Philips:“We are focused on driving profitable growth and delivering better care for more people. We built order intake growth momentum, supported by our recently launched AI-powered innovations. Our multi-year agreement with the Indonesian Ministry of Health reinforces the impact for patients of our industry-leading innovations as we provide nationwide coverage for image-guided therapy, expanding access...

Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infections Study completion expected in Q1 2028Allschwil, Switzerland, July 29, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today the initiation of FORWARD-IM, a phase 3 registrational study evaluating the efficacy and safety of its broad-spectrum antifungal fosmanogepix for the treatment of adult patients with invasive mold infections.[1] Fosmanogepix is a first-in-class antifungal with a novel mechanism of action and is available in both intravenous and oral formulations. It has been evaluated for efficacy and safety in a phase 1 and phase 2 program, including three open-label phase 2 studies for...

Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Philips Azurion image-guided therapy systemDoctor and patient in IndonesiaJuly 29, 2025Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia Combines cutting-edge treatment technology, services and training to strengthen Indonesia’s health infrastructureAmsterdam, the Netherlands and Jakarta, Indonesia – In a major step toward transforming healthcare delivery, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and the Indonesia’s Ministry of Health today announced plans to deploy state-of-the-art image-guided therapy systems nationwide, as part of their signed agreements,...

Amundi: First half and second quarter 2025 results

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Amundi: First half and second quarter 2025 results Record inflows of +€52bn in the first half of the yearInflowsalready at full year 2024 level Assets under management1 at an all-time high of €2.27tn at end-June 2025, +5% June/June despite the negative forex effect Net inflows +€52bn in H1, of which +€20bn in Q2+€48bn in medium-to-long-term assets2 (MLT) in H1 Record half-year net inflows for Institutionals: +€31bn Growth in profit before tax First half 2025: profit before tax3,4 €895m, up +4% H1/H14:Driven by revenue growth (+5%) Cost control, with a cost-income ratio at 52.5%3 Continued success on strategic pillars Partnership with Victory Capital finalised on 1 AprilStrong H1 inflows in strategic priorities:Third-party...

SDHG’s Lead in Electricity-Computing Integration Helps Market Cap Hit HK$100 Billion

Written by Customer Service on July 29, 2025. Posted in Public Companies.

SDHG market cap hit HK$100 billion for the first time, as stock price surged 200+ percent in 2025 From 2021 to 2024, SDHG’s total assets more than tripled, from RMB 21.43 billion to RMB 66.17 billion Dazzling success attributed to SDHG’s two-pronged strategy of smart investing in new energy and computing power Electricity-Computing Integration model places SDHG in unique position to lead industry SDHG’s outstanding ability to align key businesses with national policy priorities wins dedicated government supportHONG KONG, July 29, 2025 (GLOBE NEWSWIRE) — Shandong Hi-Speed Holdings Group Ltd. (00412.HK) shares rose to HK$17.26 at closing on Monday, July 28, sending the market cap of the strongly growing company to HK$103.9 billion. SDHG market cap exceeded HK$100 billion for the first time on July 11. The fact that it has since...

Questerre announces definitive agreement to acquire 100% of PX Energy

Written by Customer Service on July 29, 2025. Posted in Mergers And Acquisitions.

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) — Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) is pleased to announce that it has entered into a definitive agreement (the “Definitive Agreement”) to acquire 100% of Parana Xisto SA (“PX Energy”), a privately held shale oil production and refining company based in southern Brazil by way of acquisition of the shares of its indirect parent companies, Forbes & Manhattan Resources Inc. (“F&M Resources”) and Forbes Participaҫões Ltda (the “Acquisition”). “This acquisition is a rare opportunity for us to gain the expertise and capacity to advance our multi-billion barrel oil shale resource in Jordan(1)....

SIKA ACHIEVES GLOBAL GROWTH OF 1.6% IN LOCAL CURRENCIES AND EXPANDS ITS PROFIT MARGIN

Written by Customer Service on July 29, 2025. Posted in Public Companies.

Ad Hoc announcement pursuant to Article 53 of the Listing Rules of the SIX Exchange Regulation SIKA ACHIEVES GLOBAL GROWTH OF 1.6% IN LOCAL CURRENCIES AND EXPANDS ITS PROFIT MARGINSales of CHF 5,676.4 million (previous year: CHF 5,834.8 million) in first half of the year 1.6% sales increase in local currencies, with 0.6% attributable to organic growth and 1.0% to acquisition effect Weaker US dollar predominantly responsible for high foreign currency impact of -4.3% Material margin at a consistently high level of 55.1% (previous year: 55.1%) EBITDA margin increased to 18.9% (previous year: 18.7%), supported by strong synergy momentum; raised MBCC synergy targets for 2025 and 2026 by CHF 20 million Targeted investments in future growth:Strategic acquisition of Elmich (Singapore), Cromar (UK), HPS (USA), and Gulf Additive (Qatar) Global...

QCI Announces Acquisition of VizExplorer, Establishes Itself as A Data Activation Powerhouse and Fuels Growth with Expanded Product Suite

Written by Customer Service on July 29, 2025. Posted in Mergers And Acquisitions.

LAS VEGAS, July 28, 2025 (GLOBE NEWSWIRE) — Quick Custom Intelligence (QCI) is proud to announce its new status as a powerhouse in the casino and resort data activation world, following a strategic acquisition of VizExplorer and sustained global expansion. Armed with the combined strengths of QCI’s cutting-edge Artificial Intelligence platform and VizExplorer’s renowned analytics intellectual property, the company is uniquely positioned to drive unprecedented growth. This development enables QCI to invest heavily in an expanded product offering, delivering deeper and wider solutions for a gaming industry that is rapidly diversifying in scope and needs. Over the past year, QCI has dramatically extended its reach and capabilities. The company’s advanced software is now deployed in over 250 casino resorts across North America, Europe,...

QCI Co-Founders Andrew Cardno and Dr. Ralph Thomas Reunite with VizExplorer

Written by Customer Service on July 28, 2025. Posted in Mergers And Acquisitions.

SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) — Quick Custom Intelligence (QCI) today announced the acquisition of VizExplorer, bringing the acclaimed casino analytics platform back under the leadership of its original visionaries, Dr. Ralph Thomas and Andrew Cardno. As innovators behind both VizExplorer and QCI, Thomas and Cardno expressed pride and excitement at “getting VizExplorer back” and integrating its powerful tools into QCI’s growing suite of solutions. This reunion not only marks a personal milestone for the founders, but also promises to enhance QCI’s offerings with VizExplorer’s unique technologies and proven industry track record blog.vizexplorer.com sccgmanagement.com. “VizExplorer was our brainchild years ago, and we poured our knowledge and passion into developing ground-breaking analytics for the gaming industry,”...

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

Written by Customer Service on July 28, 2025. Posted in Public Companies.

Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 depositsBroad label includes adults and adolescents with C3G or primary IC-MPGN, and post-transplant C3G disease recurrenceWell-established safety profile, consistent across >2,200 patient years in approved indicationsC3G and primary IC-MPGN are rare kidney diseases with high risk of kidney failureConference call tomorrow at 8:00 a.m. ETWALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals